Hackman Jeffrey S. — SEC insider filings

SEC reporting owner CIK 1926254. 18 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2022-08-11 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
FENNEC PHARMACEUTICALS INC. (FENC)Chief Executive Officer, Director142 legs · 15,000 sh · $104,602—18
Comera Life Sciences Holdings, Inc. (CMRA)See Remarks., Director41 leg · 47,600 sh · $98,056—3

Insider filings — Hackman Jeffrey S.

FiledFormIssuerReported transactionsSource
2026-11-024FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-10-134FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 2,224 @ $5.53EDGAR
2026-10-014FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-08-314FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-08-034FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-07-014FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-06-014FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 1,159 @ $0EDGAR
2026-05-014FENNEC PHARMACEUTICALS INC. (FENC)Option exercise (M): 1,159 @ $0EDGAR
2026-04-024FENNEC PHARMACEUTICALS INC. (FENC)Option exercise (M): 16,695 @ $0 · Option exercise (M): 1,159 @ $0 · Option exercise (M): 13,943 @ $0 · Grant/award (A): 200,000 (derivative) @ $5.77EDGAR
2026-02-194FENNEC PHARMACEUTICALS INC. (FENC)Option exercise (M): 13,710 @ $0EDGAR
2025-05-194FENNEC PHARMACEUTICALS INC. (FENC)Purchase (P): 1,035 @ $6.75 · Purchase (P): 13,965 @ $6.99EDGAR
2025-04-034/AFENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-034FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-08-194FENNEC PHARMACEUTICALS INC. (FENC)Grant/award (A): 400,000 (derivative) @ $5.58EDGAR
2023-09-284Comera Life Sciences Holdings, Inc. (CMRA)Grant/award (A): 600,000 (derivative) @ $0EDGAR
2023-02-164Comera Life Sciences Holdings, Inc. (CMRA)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-09-124Comera Life Sciences Holdings, Inc. (CMRA)Purchase (P): 47,600 @ $2.06EDGAR
2022-08-114Comera Life Sciences Holdings, Inc. (CMRA)Grant/award (A): 300,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1926254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs